Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2018

Apr 26, 2018

30339_dirs_2018-04-26_e10c2851-0bb5-4351-a722-5366981a85d1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-04-24

Reporting Person: Green Eric Mark (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-24 Common Stock F 7716.00 $92.00 Disposed 62997.0865 Direct

Footnotes

F1: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award.